COVID-19 vaccination in Algeria

Last updated

COVID-19 vaccination in Algeria
Date29 January 2021
Locationvaccination clinics
Cause COVID-19 pandemic
Participants2,500,000 doses administered Sputnik V and Oxford-AstraZeneca
(6 June 2021)
2,500,000 Total vaccinated people
(to which the first and second dose of vaccine were administered)
Footage https://corona-dz.live/

On 29 January 2021, Algeria launched a COVID-19 vaccination campaign, a day after receiving its first shipment of 50,000 doses of the Russia's Sputnik V vaccine. As of 6 June 2021, around 2.5 million doses have been administered. [1] [2] Algeria is currently vaccinating its population with both Sputnik V and Oxford-AstraZeneca vaccines. [3] [4]

Contents

Background

Data Reporting

Algeria has reported on administering over 2.5 million doses of the vaccine. Data is only reported every few weeks or months apart without secondary dose information. [5] [6]

History

Timeline

January 2021

On 28 January 2021, Algeria received 50,000 doses of Russia's Sputnik V vaccine which landed at Algiers International Airport. [7]

On 29 January 2021, Algeria launched a coronavirus vaccination campaign, a day after receiving its first shipment of 50,000 doses of Russia's Sputnik V vaccine. [8]

February 2021

On 1 February, 50,000 doses of the Oxford–AstraZeneca COVID-19 vaccine arrived. [9]

On 25 February 2021, Algeria received 200,000 more vaccines from China. [10]

April 2021

364,800 doses of the Oxford-AstraZeneca vaccine were delivered on 3 April through the COVAX pillar. [11] [12]

On 7 April, minister Lotfi Benbahmad announced that an agreement had been reached to produce Sputnik V at Saidal's manufacturing plant in Constantine. [13] [14]

August 2021

By the end of the month, 4.1 million vaccine doses had been administered. [15]

September 2021

By the end of the month, 10.2 million vaccine doses had been administered. [15]

October 2021

By the end of the month, 11.2 million vaccine doses had been administered while 27% of the target population had been fully vaccinated. [15]

November 2021

By the end of the month, 12.1 million vaccine doses had been administered while 30% of the target population had been fully vaccinated. [15]

December 2021

By the end of the month, 12.5 million vaccine doses had been administered while 31% of the target population had been fully vaccinated. [15]

Progress

Cumulative vaccinations in Algeria [16]

Daily vaccinations chart of Algeria

Related Research Articles

COVAX Initiative to provide COVID-19 vaccines

COVID-19 Vaccines Global Access, abbreviated as COVAX, is a worldwide initiative aimed at equitable access to COVID-19 vaccines directed by the GAVI vaccine alliance, the Coalition for Epidemic Preparedness Innovations (CEPI), and the World Health Organization (WHO). It is one of the three pillars of the Access to COVID-19 Tools Accelerator, an initiative begun in April 2020 by the WHO, the European Commission, and the government of France as a response to the COVID-19 pandemic. COVAX coordinates international resources to enable low-to-middle-income countries equitable access to COVID-19 tests, therapies, and vaccines. UNICEF is the key delivery partner, leveraging its experience as the largest single vaccine buyer in the world and working on the procurement of COVID-19 vaccine doses, as well logistics, country readiness and in-country delivery.

The COVID-19 vaccination program in the Philippines is an ongoing mass immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in India Immunisation programme against COVID-19 in India

India began administration of COVID-19 vaccines on 16 January 2021. As of 16 January 2022, India has administered over 1.57 billion doses overall, including first, second and precautionary (booster) doses of the currently approved vaccines. In India, 89% of the eligible population has received at least one shot, and 64% of the eligible population is fully vaccinated.

COVID-19 vaccination in Albania

The COVID-19 vaccination campaign in Albania is a mass immunization campaign that was put in place by the Albanian authorities in order to respond to the ongoing COVID-19 pandemic. It started on 11 January 2021.

The COVID-19 vaccination in Morocco is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Angola is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. As of 15 June 2021, Angola has administered 1,314,375 doses of vaccines.822,109 people with the first dose and 492,266 people fully vaccinated. Angola began their vaccination program shortly after receiving their first shipment of Oxford AstraZeneca vaccine in early March 2021.

COVID-19 vaccination in Botswana is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Burkina Faso

Burkina Faso started vaccinating against COVID-19 on 2 June 2021.

Cape Verde has begun vaccinations against COVID-19.

COVID-19 vaccination in Africa Immunisation programme against COVID-19 in Africa

COVID-19 vaccination programs have begun in many countries and territories in Africa. In June 2021, the World Health Organization predicted that 47 of Africa's 54 nations would fall short of the aim of vaccinating 10% of their people by September 2021. In June, Africa accounted for fewer than 1% of worldwide vaccine doses delivered.

COVID-19 vaccination in Ghana

COVID-19 vaccination in Ghana began on Monday 1 March 2021 after the country became the first recipient of the Oxford-AstraZeneca COVID-19 vaccine as part of the COVAX initiative. As of 6 June 2021, Ghana has administered 1,230,000 vaccine doses.

COVID-19 vaccination in Vietnam Plan to immunize against COVID-19 in Vietnam

The COVID-19 vaccination in Vietnam is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in response to the ongoing pandemic in the country. Following the approval of the Oxford–AstraZeneca COVID-19 vaccine on 30 January 2021, vaccinations commenced on 8 March 2021, and will continue throughout the year with the goal of vaccinating 80% of the population by June 2022. The Sputnik V was later approved for use on 23 March 2021. The Sinopharm BIBP vaccine was approved for emergency use on 4 June 2021, while Pfizer–BioNTech COVID-19 vaccine, Moderna COVID-19 vaccine and Janssen COVID-19 vaccine were approved on 12 June 2021, 29 June 2021, and 15 July 2021, respectively. Vietnam approved Abdala vaccine from Center for Genetic Engineering and Biotechnology on 18 September 2021, and Covaxin from Bharat Biotech on 10 November 2021.

COVID-19 vaccination in Mexico Plan to immunize against COVID-19

COVID-19 vaccination in Mexico is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Nigeria Plan to immunize against COVID-19

COVID-19 vaccination in Nigeria is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. Vaccination began on 5 March 2021. As of 31 December 2021, 10,457,893 people have received their first dose a COVID-19 vaccine, and 4,515,006 have received their second dose.

COVID-19 vaccination in Bangladesh Immunisation programme against COVID-19 in Bangladesh

Bangladesh began the administration of COVID-19 vaccines on 27 January 2021 while mass vaccination started on 7 February 2021.

COVID-19 vaccination in Sri Lanka Plan to immunize against COVID-19

COVID-19 vaccination in Sri Lanka is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, in response to the ongoing pandemic in the country. As of late July, the Sinopharm BIBP vaccine accounted for 78% of the total 13.8 million vaccines obtained by Sri Lanka to date. The United States donated over 1.5 million Moderna vaccine through COVAX.

COVID-19 vaccination in Djibouti is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Egypt is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Eswatini is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in the Democratic Republic of the Congo is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

References

  1. "Algeria launches coronavirus vaccination campaign". SABC News - Breaking news, special reports, world, business, sport coverage of all South African current events. Africa's news leader. 31 January 2021. Retrieved 6 March 2021.
  2. "Aps Algeria Government". APS. Retrieved 7 March 2021.
  3. "Algeria: total COVID-19 vaccine doses 2021". Statista. Retrieved 16 June 2021.
  4. "Algeria: the latest coronavirus counts, charts and maps". graphics.reuters.com. Retrieved 16 June 2021.
  5. "Algeria sets up mobile centres to speed up its COVID-19 vaccination drive". SABC News - Breaking news, special reports, world, business, sport coverage of all South African current events. Africa's news leader. 10 June 2021. Retrieved 16 June 2021.
  6. "Algeria Allocates Mobile COVID-19 Vaccination Clinics". Asharq AL-awsat. Retrieved 16 June 2021.
  7. AfricaNews (30 January 2021). "Algeria's COVID-19 Vaccination Campaign Kicks Off with Sputnik V". Africanews. Retrieved 7 March 2021.
  8. "Algeria launches its Covid-19 vaccination campaign". France 24. 30 January 2021. Retrieved 7 March 2021.
  9. "Coronavirus : first batch of AstraZeneca vaccine arrives in Algiers". Algeria Press Service. 1 February 2021. Retrieved 11 May 2021.
  10. "StackPath". dailynewsegypt.com. Retrieved 7 March 2021.
  11. "Algeria receives 364,800 COVID-19 vaccine doses through the COVAX Facility". Unicef. 5 April 2021. Retrieved 11 May 2021.
  12. "COVAX roll-out - Algeria". www.gavi.org. Retrieved 16 June 2021.
  13. Sossoukpè, Carine (8 April 2021). "Coronavirus: Algeria to start production of Sputnik V vaccine from September". Ecofin Agency. Retrieved 11 May 2021.
  14. "Algeria launches its Covid-19 vaccination campaign". France 24. 30 January 2021. Retrieved 16 June 2021.
  15. 1 2 3 4 5 Africa COVID-19 dashboard (World Health Organization).
  16. "owid/covid-19-data". GitHub. Retrieved 7 March 2021.